Articles

Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia

Department of Pathology, Hematopathology Diagnostic Service
Department of Medicine, Leukemia Service
Center for Hematologic Malignancies
Epidemiology and Biostatistics
Department of Pathology, Hematopathology Diagnostic Service
Department of Pathology, Hematopathology Diagnostic Service
Clinical Pharmacy
Center for Hematologic Malignancies
Center for Hematologic Malignancies
Center for Hematologic Malignancies
Center for Hematologic Malignancies
Department of Medicine, Leukemia Service
Department of Medicine, Leukemia Service
Department of Medicine, Leukemia Service
Department of Medicine, Leukemia Service
Department of Medicine, Leukemia Service
Department of Medicine, Leukemia Service;Center for Cell Engineering
Department of Medicine, Leukemia Service
Department of Medicine, Leukemia Service
Department of Medicine, Leukemia Service
Department of Medicine, Leukemia Service;Center for Hematologic Malignancies;Human Oncology and Pathogenesis Program
Department of Pathology, Cytogenetics Laboratory
Department of Medicine, Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Department of Medicine, Leukemia Service
Department of Medicine, Leukemia Service
Department of Pathology, Hematopathology Diagnostic Service
Vol. 104 No. 7 (2019): July, 2019 https://doi.org/10.3324/haematol.2018.203018